Published in Br J Cancer on October 07, 2002
A Phase II Study of Isolated Hepatic Perfusion (IHP) in Patients With Ocular Melanoma | NCT00062933
Clinical evaluation of in vitro chemosensitivity testing: the example of uveal melanoma. J Cancer Res Clin Oncol (2004) 1.39
Human polynucleotide phosphorylase selectively and preferentially degrades microRNA-221 in human melanoma cells. Proc Natl Acad Sci U S A (2010) 1.08
Systemic treatment of metastatic uveal melanoma: review of literature and future perspectives. Cancer Med (2013) 1.02
Current and emerging treatment options for uveal melanoma. Clin Ophthalmol (2013) 0.94
Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial. Ann Oncol (2014) 0.88
Minimally invasive intra-arterial regional therapy for metastatic melanoma: isolated limb infusion and percutaneous hepatic perfusion. Expert Opin Drug Metab Toxicol (2011) 0.79
Minimally invasive liver resection to obtain tumor-infiltrating lymphocytes for adoptive cell therapy in patients with metastatic melanoma. World J Surg Oncol (2012) 0.79
The relation between c-myc expression and interferon sensitivity in uveal melanoma. Br J Ophthalmol (2004) 0.78
Quality of evidence about effectiveness of treatments for metastatic uveal melanoma. Trans Am Ophthalmol Soc (2008) 0.78
First experience on laparoscopic near-infrared fluorescence imaging of hepatic uveal melanoma metastases using indocyanine green. Surg Innov (2014) 0.78
Management of uveal melanoma: a consensus-based provincial clinical practice guideline. Curr Oncol (2016) 0.76
Adjuvant Therapy of Uveal Melanoma: Current Status. Ocul Oncol Pathol (2014) 0.76
Arterial Therapies of Non-Colorectal Liver Metastases. Viszeralmedizin (2015) 0.75
Modern prospection for hepatic arterial infusion chemotherapy in malignancies with liver metastases. Int J Hepatol (2013) 0.75
Surgical resection plus biotherapy/chemotherapy improves survival of hepatic metastatic melanoma. World J Hepatol (2012) 0.75
Prognosis and treatment of disseminated uveal melanoma. Cancer (1993) 1.98
Survival of patients with metastases from uveal melanoma. Ophthalmology (1991) 1.80
Posterior uveal melanoma. The Swedish perspective. Acta Ophthalmol Scand (1996) 1.75
Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors. Cancer (1995) 1.65
Uveal melanoma: natural history and treatment options for metastatic disease. Melanoma Res (1999) 1.19
Management of uveal melanoma. A continuing dilemma. Cancer (1993) 1.15
Screening for metastatic malignant melanoma of the uvea revisited. Cancer (1999) 1.10
The treatment of metastatic uveal melanoma. Eur J Cancer (1998) 1.07
Treatment of liver metastases from uveal melanoma by combined surgery-chemotherapy. Eur J Surg Oncol (1998) 1.05
The ex vivo chemosensitivity profile of choroidal melanoma. Anticancer Drugs (1997) 1.03
BOLD+interferon in the treatment of metastatic uveal melanoma: first report of active systemic therapy. J Exp Clin Cancer Res (1997) 0.99
Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapy. J Clin Oncol (1997) 0.99
Expression of angiogenic and immunosuppressive factors by uveal melanoma cell lines. Melanoma Res (1999) 0.98
Adoptive T cell immunotherapy of human uveal melanoma targeting gp100. J Immunol (2000) 0.87
Mechanism of action of fotemustine, a new chloroethylnitrosourea anticancer agent: evidence for the formation of two DNA-reactive intermediates contributing to cytotoxicity. Biochemistry (1997) 0.86
HLA expression in a primary uveal melanoma, its cell line, and four of its metastases. Br J Ophthalmol (1997) 0.86
Inverse correlation between expression of HLA-B and c-myc in uveal melanoma. J Pathol (1997) 0.85
Diagnosis and treatment of uveal melanoma. Semin Oncol (1996) 0.84
Sequential interferon-alpha2b, interleukin-2 and fotemustine for patients with metastatic melanoma. Melanoma Res (2000) 0.83
Interleukin-2 therapy for metastatic uveal melanoma. Eur J Cancer (1992) 0.83
The effects of stress in normal and adrenalectomized mice. Eur J Immunol (1985) 0.81
Histamine: a novel approach to cancer immunotherapy. Cancer Invest (2000) 0.81
Immunotherapy of uveal melanoma. Dev Ophthalmol (1999) 0.80
[Therapy of metastatic malignant uveal melanoma]. Hautarzt (2001) 0.79
[Immunochemotherapy of metastatic uveal melanoma with interferon alfa-2b, interleukin-2 and fotemustine. Case reports and review of the literature]. Hautarzt (1998) 0.79
Fotemustine and interferon alpha2b in metastatic malignant melanoma. J Cancer Res Clin Oncol (1998) 0.77
Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma. J Clin Oncol (2000) 9.70
Proliferating dendritic cell progenitors in human blood. J Exp Med (1994) 7.67
Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med (1998) 7.48
Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke (1995) 6.49
REACTIVITY OF INTACT BLOOD VESSELS OF THE FINGERS AND TOES TO SENSORY STIMULI IN NORMAL RESTING ADULTS, IN PATIENTS WITH HYPERTENSION, AND IN SENILE SUBJECTS. J Clin Invest (1942) 6.06
High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J Exp Med (1996) 5.29
Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Methods (1996) 4.87
Detection of intracellular cytokines by flow cytometry. J Immunol Methods (1993) 4.54
Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J Exp Med (1999) 4.20
Current trends in microsatellite genotyping. Mol Ecol Resour (2011) 3.21
Drosophila mushroom body mutants are deficient in olfactory learning. J Neurogenet (1985) 3.19
Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application. J Immunol Methods (1999) 3.09
Antigen presentation in extracellular matrix: interactions of T cells with dendritic cells are dynamic, short lived, and sequential. Immunity (2000) 2.93
Biological communities at the Florida escarpment resemble hydrothermal vent taxa. Science (1984) 2.66
Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization. Proc Natl Acad Sci U S A (2000) 2.46
Organization of the ribosomal ribonucleic acid genes in various wild-type strains and wild-collected strains of Neurospora. Mol Gen Genet (1984) 2.35
A radiation hybrid map of the zebrafish genome. Nat Genet (1999) 2.31
Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. J Natl Cancer Inst (1996) 2.28
Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. Neurosurgery (1998) 2.22
Disappearance of certain acidic organelles (endosomes and Langerhans cell granules) accompanies loss of antigen processing capacity upon culture of epidermal Langerhans cells. J Exp Med (1990) 2.21
Hereditary hemorrhagic telangiectasia: effective protocol for embolization of hepatic vascular malformations--experience in five patients. Radiology (1998) 2.12
Skin cancer and water arsenic in Lane County, Oregon. Cancer (1976) 1.95
Retinoblastoma gene product activates expression of the human TGF-beta 2 gene through transcription factor ATF-2. Nature (1992) 1.93
Explaining math: gesturing lightens the load. Psychol Sci (2001) 1.92
Mutant strains (nit) of Salmonella typhimurium with a pleiotropic defect in nitrogen metabolism. J Bacteriol (1976) 1.89
Induction of maturation of human blood dendritic cell precursors by measles virus is associated with immunosuppression. Proc Natl Acad Sci U S A (1997) 1.85
Mutations that alter the covalent modification of glutamine synthetase in Salmonella typhimurium. J Bacteriol (1978) 1.84
Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options. Eur J Neurol (2009) 1.76
House dust mite-specific T cells in the skin of subjects with atopic dermatitis: frequency and lymphokine profile in the allergen patch test. J Allergy Clin Immunol (1992) 1.73
Surgical management of symptomatic spinal metastases. Postoperative outcome and quality of life. Spine (Phila Pa 1976) (1999) 1.73
Lack of clinical efficacy of imatinib in metastatic melanoma. Br J Cancer (2005) 1.66
Pathophysiology of impaired right and left ventricular function in chronic embolic pulmonary hypertension: changes after pulmonary thromboendarterectomy. Chest (2000) 1.65
A novel class C beta-lactamase (FOX-2) in Escherichia coli conferring resistance to cephamycins. Antimicrob Agents Chemother (1997) 1.64
Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanoma. Ann Oncol (2014) 1.63
Mucosal tolerance as therapy of type I allergy: intranasal application of recombinant Bet v 1, the major birch pollen allergen, leads to the suppression of allergic immune responses and airway inflammation in sensitized mice. Clin Exp Allergy (2002) 1.63
Genetic analysis of brain circuits underlying pheromone signaling. Annu Rev Genet (2006) 1.60
Melanocytes as "sensory" and regulatory cells in the epidermis. J Theor Biol (1993) 1.55
K(+)-aggravated myotonia: destabilization of the inactivated state of the human muscle Na+ channel by the V1589M mutation. J Physiol (1994) 1.54
Effects of suckling on hypothalamic-pituitary-adrenal axis responses to psychosocial stress in postpartum lactating women. J Clin Endocrinol Metab (2001) 1.53
[Laryngeal tube versus laryngeal mask airway in anaesthetised non-paralysed patientsA comparison of handling and postoperative morbidity]. Anaesthesist (2004) 1.52
Double-blind placebo-controlled house dust mite control measures in adult patients with atopic dermatitis. Br J Dermatol (2001) 1.49
Mechanisms of deficient interferon-gamma production in atopic diseases. Clin Exp Allergy (1999) 1.48
Rapid quantitation of proinflammatory and chemoattractant cytokine expression in small tissue samples and monocyte-derived dendritic cells: validation of a new real-time RT-PCR technology. J Immunol Methods (2000) 1.48
Successful treatment of a saphenous vein graft perforation with an autologous vein-covered stent. Catheter Cardiovasc Interv (1999) 1.47
A human nuclear-localized chaperone that regulates dimerization, DNA binding, and transcriptional activity of bZIP proteins. Mol Cell (1999) 1.47
Transcranial brain sonography findings predict disease progression in multiple sclerosis. Neurology (2009) 1.46
Normal left ventricular dimensions and function: interstudy reproducibility of measurements with cine MR imaging. Radiology (1990) 1.45
Good vibrations: oscillatory phase shapes perception. Neuroimage (2012) 1.45
Recognition of bZIP proteins by the human T-cell leukaemia virus transactivator Tax. Nature (1995) 1.44
Human mast cells produce IL-8. J Immunol (1993) 1.44
Prognostic factors of overall survival in patients with delayed lymph node dissection for cutaneous malignant melanoma. Melanoma Res (2000) 1.44
Clinical phase II study of pegylated liposomal doxorubicin as second-line treatment in disseminated melanoma. Onkologie (2004) 1.43
Hepatitis B vaccination of high-risk individuals in the canton of Zurich. Eur J Clin Microbiol (1983) 1.43
Spinal metastases from renal cell carcinoma: effect of preoperative particle embolization on intraoperative blood loss. AJNR Am J Neuroradiol (2001) 1.42
Inverse correlation of domestic exposure to Dermatophagoides pteronyssinus antigen patch test reactivity in patients with atopic dermatitis. Clin Exp Allergy (1999) 1.42
Results of a surveillance programme for patients at high risk of malignant melanoma using digital and conventional dermoscopy. Eur J Cancer Prev (2004) 1.41
Identification of p90RSK as the probable CREB-Ser133 kinase in human melanocytes. Cell Growth Differ (1995) 1.41
Gd-EOB-DTPA and Yb-EOB-DTPA: two prototypic contrast media for CT detection of liver lesions in dogs. Radiology (1997) 1.40
Interstudy reproducibility of dimensional and functional measurements between cine magnetic resonance studies in the morphologically abnormal left ventricle. Am Heart J (1990) 1.40
Expression of interleukin-8 detected by in situ hybridization correlates with worse prognosis in primary cutaneous melanoma. J Pathol (1999) 1.40
Capillary leak syndrome in a patient treated with interleukin 2 fusion toxin for cutaneous T-cell lymphoma. J Am Acad Dermatol (2000) 1.39
Activating transcription factor-1 can mediate Ca(2+)- and cAMP-inducible transcriptional activation. J Biol Chem (1993) 1.39
Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation. Blood (2001) 1.38
TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours. Br J Cancer (2013) 1.38
Rapid loss of microvascular integrin expression during focal brain ischemia reflects neuron injury. J Cereb Blood Flow Metab (2001) 1.37
Different effects on gating of three myotonia-causing mutations in the inactivation gate of the human muscle sodium channel. J Physiol (1995) 1.36
Helicobacter pylori causes DNA damage in gastric epithelial cells. Carcinogenesis (2000) 1.34
Sensitive PCR method for the detection and real-time quantification of human cells in xenotransplantation systems. Br J Cancer (2002) 1.33
Sequential expression of functions during macrophage differentiation in murine bone marrow liquid cultures. Eur J Immunol (1980) 1.33
Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1+ melanoma patients by mature monocyte-derived dendritic cells. J Immunol (2000) 1.32
Stereolithography in oral and maxillofacial operation planning. Int J Oral Maxillofac Surg (1995) 1.32
Frequency of symptom distress and poor prognostic indicators in palliative cancer patients admitted to a tertiary palliative care unit, hospices, and acute care hospitals. J Palliat Care (2000) 1.31
Purine nucleoside phosphorylase. 1. Structure-function studies. Biochemistry (1997) 1.30
Increased expression of epidermal fatty acid binding protein, cofilin, and 14-3-3-sigma (stratifin) detected by two-dimensional gel electrophoresis, mass spectrometry and microsequencing of drug-resistant human adenocarcinoma of the pancreas. Electrophoresis (1999) 1.30
Reduced serum 25-hydroxyvitamin D levels in stage IV melanoma patients. Anticancer Res (2009) 1.29
Retinoblastoma. A transcriptional tryst. Nature (1991) 1.28
A familial syndrome of renal, genital, and middle ear anomalies. J Pediatr (1968) 1.27
Phase 2 trial of vaccination with tyrosinase peptides and granulocyte-macrophage colony-stimulating factor in patients with metastatic melanoma. J Immunother (2000) 1.27
Superparamagnetic iron oxide-enhanced MRI of atherosclerotic plaques in Watanabe hereditable hyperlipidemic rabbits. Invest Radiol (2000) 1.27
Reduction in stroke with gemfibrozil in men with coronary heart disease and low HDL cholesterol: The Veterans Affairs HDL Intervention Trial (VA-HIT). Circulation (2001) 1.25
Public awareness of risk factors and screening for colorectal cancer in Europe. Eur J Cancer Prev (2004) 1.25
Serological detection of cutaneous T-cell lymphoma-associated antigens. Proc Natl Acad Sci U S A (2001) 1.24
Procalcitonin as a diagnostic tool in lower respiratory tract infections and tuberculosis. Eur Respir J (2003) 1.24
Human decidua contains potent immunostimulatory CD83(+) dendritic cells. Am J Pathol (2000) 1.24
Molecular cloning of RhD cDNA derived from a gene present in RhD-positive, but not RhD-negative individuals. Blood (1993) 1.23
The chemokine RANTES is secreted by human melanoma cells and is associated with enhanced tumour formation in nude mice. Br J Cancer (1999) 1.22
Expression of leptin and leptin receptor isoforms in the human stomach. Gut (2000) 1.22
Estimating the time needed for induction of anaesthesia and its importance in balancing anaesthetists' and surgeons' waiting times around the start of surgery. Anaesthesia (2011) 1.22
Interferon alfa-2a and interleukin-2 with or without cisplatin in metastatic melanoma: a randomized trial of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group. J Clin Oncol (1997) 1.20
Evaluation of skin vasomotor reflexes by using laser Doppler velocimetry. Mayo Clin Proc (1983) 1.20
Relationship between nutrition and development in Kenyan toddlers. J Pediatr (1989) 1.18
Magnetic resonance imaging of atherosclerotic plaques using superparamagnetic iron oxide particles. J Magn Reson Imaging (2001) 1.18
Deficient IL-12p70 secretion by dendritic cells based on IL12B promoter genotype. Genes Immun (2004) 1.18